US Broker Ratings

Merck & Company, Inc. (MRK) Stock Analysis: Strong Dividend Yield and Analyst Optimism Highlight Investment Potential

Merck & Company, Inc. (NYSE: MRK) stands as a stalwart in the healthcare sector, particularly within the general drug manufacturing industry. With an impressive market capitalization..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Market with an 8.9% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a formidable player in the healthcare sector, commands attention with its robust presence in the medical devices industry. Headquartered in Plano,..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring the 229.56% Potential Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biotechnology sector with a compelling growth narrative driven by its innovative cell therapy solutions. Headquartered in Somerset,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 45% Potential Upside Amidst Robust Revenue Growth

Inspire Medical Systems, Inc. (NYSE: INSP), a notable player in the healthcare sector specializing in medical devices, is gaining significant attention from investors due to its..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Play with 47% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY) is making significant strides in the healthcare information services sector, capturing the attention of investors with its innovative cloud-based payment solutions...

Option Care Health, Inc. (OPCH) Stock Analysis: A Healthcare Heavyweight with a 12.13% Upside Potential

Option Care Health, Inc. (OPCH) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bannockburn, Illinois, this..

Nuvalent, Inc. (NUVL) Stock Analysis: Biotech’s Potential 36.52% Upside Amidst Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biopharmaceutical sector, is drawing significant attention from investors, driven by its promising pipeline of cancer therapies and..

iRhythm Technologies (IRTC) Stock Analysis: A 25% Potential Upside in Healthcare Innovation

iRhythm Technologies, Inc. (NASDAQ: IRTC) is at the forefront of digital healthcare innovation, specializing in ambulatory cardiac monitoring services that diagnose arrhythmias. With a current market..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 13.4% Potential Upside with Innovative Medical Technologies

Globus Medical, Inc. (NYSE: GMED) stands as a beacon of innovation in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Viatris Inc. (VTRS) Stock Analysis: Navigating Challenges with a Promising 4.02% Dividend Yield

Viatris Inc. (NASDAQ: VTRS) stands as a significant player in the healthcare sector, particularly within the specialized and generic drug manufacturing industry. With a market capitalization..

Universal Health Services, Inc. (UHS): Investor Outlook on Healthcare Giant with Over 10% Potential Upside

Universal Health Services, Inc. (UHS), a prominent player in the healthcare sector, stands as a formidable force in the medical care facilities industry in the United..

Corcept Therapeutics (CORT) Stock Analysis: Potential 51.86% Upside as Biotech Innovator Advances Pipeline

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, continues to capture investor interest with its strong position in the healthcare market. With..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 14.49% Potential Upside in Medical Devices

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, specifically within the medical devices industry, boasts a formidable market capitalization of $17.66 billion...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 25% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, specializes in developing and commercializing diagnostic and therapeutic products. With a focus on heart..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Potential and Performance Challenges in the Healthcare Sector

Medpace Holdings, Inc. (NASDAQ: MEDP) has been a noteworthy player in the healthcare sector, particularly within the diagnostics and research industry. With a market cap of..

Bio-Techne Corp (TECH) Stock Analysis: Why a 19.56% Upside Beckons Investors

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, stands as a compelling opportunity for investors seeking exposure to the healthcare industry. With a..

ADMA Biologics Inc (ADMA) Stock Analysis: Strong Analyst Consensus and 31% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, is capturing the attention of investors with its robust growth potential and strong market..

Repligen Corporation (RGEN) Stock Analysis: Exploring a Potential 16.53% Upside in the Booming Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of..

Qiagen N.V. (QGEN) Stock Report: Exploring a 10.95% Potential Upside in the Diagnostics & Research Sector

For investors keen on the healthcare sector, Qiagen N.V. (NYSE: QGEN) offers a compelling opportunity with a market cap of $9.88 billion. Specializing in diagnostics and..

Johnson & Johnson (JNJ) Stock Analysis: Poised for Steady Growth with a 1.42% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to present a promising opportunity for investors seeking stability and growth in a volatile..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds